In Poland, PCI is the dominant first-line treatment for ACS, and dual antiplatelet therapy with aspirin and clopidogrel is widely used, though novel antiplatelet agents were rarely utilized during the 2010-2011 study period.
No takes yet. Share an insight, caveat, or question.
Observational patterns in ACS antithrombotic use remain hypothesis-generating; leaves open optimal long-term strategies.
Wojtkowska et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: